News | June 24, 2023
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Subscribe To Our Newsletter & Stay Updated
